FGF21 Enhances Neuronal Survival Post-Brain Injury
Published in Brain/Neurology.
In a groundbreaking study published in the Journal of Translational Medicine, researchers led by L. Wang, W. Li, and X. Wu have uncovered the pivotal role of Fibroblast Growth Factor 21 (FGF21) in maintaining redox homeostasis and enhancing neuronal survival following traumatic brain injury (TBI). This study, which has profound implications for the treatment of TBI, illuminates the intricate biochemical pathways that can be manipulated to protect neuronal health in the aftermath of injury.
FGF21 is a versatile peptide hormone that is primarily secreted by the liver, playing an essential role in metabolic regulation. Its neuroprotective qualities, however, have only recently begun to garner scientific attention. In their research, Wang and colleagues investigated how FGF21 interacts with SLC25A39, a mitochondrial protein responsible for transporting glutathione (GSH), a vital antioxidant. This specific interaction was highlighted as a significant mechanism through which FGF21 exerts its protective effects on neurons after TBI.
Traumatic brain injury is known to cause complex biochemical changes that can lead to oxidative stress, a condition characterized by the overproduction of reactive oxygen species (ROS). This oxidative stress is a major contributor to neuronal cell death and has been implicated in various neurodegenerative diseases. The study highlights how FGF21 can mitigate these effects by regulating the expression and function of SLC25A39, thereby facilitating GSH transport into mitochondria where it is most needed to combat oxidative stress.
https://bioengineer.org/fgf21-enhances-neuronal-survival-post-brain-injury/